Drugs / Bacteriophage cocktail spray
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04323475 | Jan 2022 → Jan 2023 | skin infection | Precisio Biotix Therapeutics, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bacteriophage cocktail spray | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04323475 ↗ |
| Modality | Other / unclassified | “cocktail of 14 bacteriophages” NCT04323475 ↗ |